{"database": "openregs", "table": "documents", "rows": [["FDA-2021-D-0669-0008", "FDA", "FDA-2021-D-0669", "S1B(R1) Addendum to S1B Testing for Carcinogenicity of Pharmaceuticals; International Council for Harmonisation; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2022-11-02T04:00:00Z", 2022, 11, null, null, "2022-11-02T12:34:04Z", "2022-23787", 0, 0, "090000648547b3db"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2021-D-0669-0008"], "units": {}, "query_ms": 0.7943679811432958, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}